Varghese P. Inchakalody
Doha, DA, Qatar
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Extracellular vesicles as diagnostic and prognostic biomarkers in non-small cell lung cancer.
Journal: Expert review of molecular diagnostics
Published: June 21, 2026
Longitudinal Plasma Proteome of Pfizer/BNT162b2 Pre- and Postbooster Vaccinated Healthy Individuals Reveals Distinct Protein Profiles upon SARS-CoV-2 Spike Protein Stimulation.
Journal: Journal of proteome research
Published: February 03, 2026
Immune checkpoint blockade in cancer: current insights and future horizons.
Journal: Discover oncology
Published: June 19, 2025
Crosstalk Between the Oncoproteins of High-Risk Human Papillomaviruses Types 16 and 18 in Colorectal Cancer Cell Models.
Journal: Cancer reports (Hoboken, N.J.)
Published: March 19, 2024
The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 26, 2023
Chronic inflammation and cancer; the two sides of a coin.
Journal: Life sciences
Published: October 22, 2023
Serum immune mediators as novel predictors of response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients with high tissue-PD-L1 expression.
Journal: Frontiers in immunology
Published: February 02, 2023
Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: potential for combined chemoimmunotherapy.
Journal: Journal of translational medicine
Published: December 22, 2022
The molecular mechanisms of apoptosis accompanied with the epigenetic regulation of the NY-ESO-1 antigen in non-small lung cancer cells treated with decitabine (5-aza-CdR).
Journal: European journal of pharmacology
Published: November 29, 2022
Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients.
Journal: Frontiers in immunology
Published: November 13, 2022
Persistence of spike-specific immune responses in BNT162b2-vaccinated donors and generation of rapid ex-vivo T cells expansion protocol for adoptive immunotherapy: A pilot study.
Journal: Frontiers in immunology
Published: October 04, 2022
Last Updated: 09/26/2026